Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04795908 · ClinicalTrials.gov registry record · NA

Combined CBIT and rTMS to Improve Tourette's Syndrome

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
3
Enrollment target

NCT04795908: Completed NA study, sponsored by University of Florida.

NCT04795908 is a NA study that has completed, run by University of Florida. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04795908, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

The investigator will apply 16 sessions of repetitive transcranial magnetic stimulation (rTMS) over 4 consecutive days for adult patients suffering from Tourette's Syndrome. Following rTMS, patients will undergo 8 sessions of Comprehensive Behavioral Intervention for Tics (CBIT) over 10 weeks via telemedicine. Clinical improvement in tic severity will be the primary outcome measure. Secondary outcome measures including underlying physiological effects will be measured via functional magnetic resonance imaginge (fMRI), high-density electroencephalograhy (HD-EEG), and TMS.

Primary Outcome

Tic severity will be measured with YGTSS. YGTSS is a clinician-rated scale used to assess tic severity, scored out of 100 where a higher score indicates greater tic frequency and severity. It includes a checklist of motor and vocal tics followed by an assessment of the number, frequency, intensity, complexity, and inference of motor tics and phonic tics - scored separately. Each of these dimensions is scored on a 0 to 5 scale. The YGTSS provides three tic severity scores: Total Motor (0 to 25);

Interventions

  • DEVICE Transcranial Magnetic Stimulation
  • BEHAVIORAL Comprehensive behavioral intervention

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2021-12-17
Est. Completion 2023-01-18
Phase NA
University of Florida

1,106 total trials

What the finished NCT04795908 record still lists

NCT04795908 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Stimulation is the first listed.

NCT04795908 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04795908 about?

NCT04795908 is a clinical study titled "Combined CBIT and rTMS to Improve Tourette's Syndrome". The investigator will apply 16 sessions of repetitive transcranial magnetic stimulation (rTMS) over 4 consecutive days for adult patients suffering from Tourette's Syndrome. Following rTMS, patients will undergo 8 sessions of Comprehensive Behavioral Intervention for Tics (CBIT) over 10 weeks via te...

What is the current status of trial NCT04795908?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2021-12-17. Estimated completion is 2023-01-18.

What interventions are being tested in trial NCT04795908?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE), Comprehensive behavioral intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04795908?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04795908's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04795908, the US trial registry maintained by the National Library of Medicine. NCT04795908 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.